Open Access
Editorial

Circulating markers in metastatic cancer: new perspectives

Irene A. George1,2,†,Janani Sambath1,2,†,Prashant Kumar1,2,3,*
1
Institute of Bioinformatics, International Technology Park, 560066 Bangalore, Karnataka, India
2
Manipal Academy of Higher Education (MAHE), 576104 Manipal, Karnataka, India
3
Somaiya Institute of Research and Consultancy (SIRAC), Somaiya Vidyavihar University (SVU), 400077 Mumbai, Maharashtra, India
DOI: 10.52586/5031 Volume 26 Issue 12, pp.1383-1385
Submited: 08 December 2021 Revised: 15 December 2021
Accepted: 20 December 2021 Published: 30 December 2021
*Corresponding Author(s):  
Prashant Kumar
E-mail:  
prashantkumar@somaiya.edu
These authors contributed equally.
Copyright: © 2021 The author(s). Published by BRI. This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).
Abstract


References

[1] Moller A. The role of exosomes in the promotion of epithelial-to-mesenchymal transition and metastasis. Frontiers in Bioscience-Landmark. 2020; 25: 1022–1057.

[2] Carvalho AS, Baeta H, Silva BC, Moraes MCS, Bodo C, Beck HC, et al. Extra-cellular vesicles carry proteome of cancer hall-marks. Frontiers in Bioscience-Landmark. 2019; 25: 398–436.

[3] Dhar R. MTiness in pseudo-malignant behavior of trophoblasts during embryo implantation. Frontiers in Bioscience-Landmark. 2021; 26: 717–743.

[4] Roy S. EMT imparts cancer stemness and plasticity: new per-spectives and therapeutic potential. Frontiers in Bioscience-Landmark. 2021; 26: 238–265.

[5] Raja R, Pandey A, Kumar P. Epithelial to mesenchymal plas-ticity: role in cancer progression. Frontiers in Bioscience-Landmark. 2019; 25: 838–873.

[6] Kumar LD. EMT in breast cancer metastasis an interplay of mi-croRNAs signaling pathways and circulating tumor cells. Fron-tiers in Bioscience-Landmark. 2020; 25: 979–1010.

[7] Kumar P. Circulating tumor cells as an emerging tool in cancer therapy. Frontiers in Bioscience-Landmark. 2020; 25: 606–631.

[8] Hassan S. Applications of RNA from circulating tumor cells. Frontiers in Bioscience-Landmark. 2020; 25: 874–892.

[9] Notani D. Beyond the coding genome non-coding mutations and cancer. Frontiers in Bioscience-Landmark. 2020; 25: 1828–1838.

[10] Sadasivam S. A perspective on challenges and opportunities in characterizing oral cancer stem cells. Frontiers in Bioscience-Landmark. 2020; 25: 1011–1021.

[11] Vidigal JA. AGO unchained Canonical and non-canonical roles of Argonaute proteins in mammals. Frontiers in Bioscience-Landmark. 2020; 25: 1–42.

[12] Singh V, Bhat R. Proteoglycan desulfation: a critical step in oncogenesis? Frontiers in Bioscience-Landmark. 2019; 25: 760–780.

[13] Singh PS. Cancer associated fibroblasts phenotypic and functional heterogeneity. Frontiers in Bioscience-Landmark. 2020; 25: 961–978.

Share and Cite
Irene A. George, Janani Sambath, Prashant Kumar. Circulating markers in metastatic cancer: new perspectives. Frontiers in Bioscience-Landmark. 2021. 26(12); 1383-1385.